The GPhC registration assessment provides a resource pack during the exam. This pack includes extracts from the BNF, BNFC, and Summary of Product Characteristics. Some Part 2 questions present SmPC extracts on screen and ask you to interpret them — testing not whether you have memorised the SmPC, but whether you can find the right piece of information and apply it correctly under time pressure.
This is an explicitly assessable skill. It is also the skill most candidates underprepare for — because it feels less like "revision" and more like "reading." But the candidates who practise SmPC navigation systematically outperform those who encounter SmPC-based questions cold on exam day.
How the Resource Pack Works in the Exam
The resource pack is digital. Extracts appear on screen alongside the question stem. You do not have access to the full emc or full BNF — you see specific sections of a specific product's SmPC, and you must work with what is provided. This is fundamentally different from the clinical workflow of searching the emc and browsing at your own pace.
The constraint is time. With approximately 1.5-2 minutes per question, you cannot read every line of a lengthy SmPC section 4.5 before answering. The skill being tested is: rapidly locating the relevant subsection within the extract, correctly interpreting its meaning in the clinical context provided, and selecting the single best answer without second-guessing.
The Pharmaceutical Journal's GPhC preparation series emphasises this point: "make full use of the main clinical information sources (e.g. BNF, SmPC and MEP)" and approach questions through applied clinical decision-making, not factual recall.
Section-by-Section: What Examiners Like to Ask
Section 4.1 (Therapeutic Indications): Licensed vs Off-Label
Examiners test whether you can distinguish licensed from unlicensed use — a core pharmacist competency. A question might present a clinical scenario where a drug is being used for a condition not listed in section 4.1 and ask: "Based on the SmPC provided, is this an appropriate licensed indication?"
The correct answer requires recognising that the use is off-label. This does not mean it is clinically wrong — many off-label uses are well-established in UK practice — but it does mean the pharmacist should be aware that additional governance applies (informed patient consent, appropriate clinical justification, documentation). The question tests your awareness of the regulatory boundary, not your opinion on the clinical merits.
Exam tip: Read section 4.1 of the extract before answering any question that mentions the drug's indication. Do not assume a drug is licensed for a particular use simply because you have seen it prescribed in practice. The SmPC defines the licence; clinical practice sometimes extends beyond it.
Section 4.2 (Posology): Dose Adjustments in Special Populations
The highest-yield SmPC subsection for GPhC questions. Examiners test: dose adjustments in renal impairment (the SmPC specifies exact GFR or creatinine clearance thresholds that the BNF may present less precisely), dose adjustments in hepatic impairment (where data exists — many SmPCs are silent, which is itself testable knowledge), paediatric dosing (mg/kg calculations using SmPC-specified dose ranges), elderly dosing (where specific guidance is provided vs "use with caution"), and maximum dose limits that differ from the general adult dose in specific populations.
Worked example 1. SmPC extract for ramipril states: "In patients with renal impairment with creatinine clearance below 30ml/min, the initial dose should not exceed 1.25mg daily and the maximum daily dose is 5mg." The question presents: Mrs A, 74 years old, eGFR 22ml/min/1.73m², currently prescribed ramipril 10mg once daily for hypertension. What is the most appropriate action?
The answer: the current dose (10mg) exceeds the SmPC maximum for this level of renal function (5mg). The dose must be reduced. The SmPC provides the specific threshold — the question tests whether you can match the patient's renal function to the SmPC adjustment.
Worked example 2. SmPC extract for a drug states under posology: "No dose adjustment is necessary in patients with mild hepatic impairment (Child-Pugh A). Use with caution in moderate hepatic impairment (Child-Pugh B). Contraindicated in severe hepatic impairment (Child-Pugh C)." A patient with Child-Pugh C cirrhosis is prescribed the drug. What is the appropriate advice? The answer: the drug is contraindicated — not "use with caution" but absolutely contraindicated at this severity level. The SmPC distinguishes three levels of hepatic impairment with different recommendations for each.
Exam tip: Always check the units in the SmPC extract. Renal function may be expressed as creatinine clearance (ml/min), eGFR (ml/min/1.73m²), or serum creatinine (micromol/L). Ensure you are comparing the patient's data with the correct measure in the SmPC — a mismatch in units leads to the wrong dose adjustment.
Section 4.3 (Contraindications): "Which Patient Should NOT Receive This Drug?"
The classic SBA stem. A list of 4-5 patients with different clinical characteristics. An SmPC extract listing contraindications. Identify the one patient for whom the drug is absolutely contraindicated.
Worked example 3. SmPC extract for an ACE inhibitor lists contraindications including: history of angioedema, bilateral renal artery stenosis, second and third trimesters of pregnancy, and concomitant use with aliskiren in patients with diabetes. Five patients are presented. Patient A has unilateral renal artery stenosis. Patient B has a history of ACE inhibitor-induced angioedema. Patient C is 12 weeks pregnant. Patient D has diabetes and takes aliskiren. Patient E has mild asthma.
The answer requires careful SmPC reading. Patient A: unilateral stenosis is not the same as bilateral — not contraindicated (but caution in section 4.4). Patient B: history of ACE inhibitor angioedema — contraindicated. Patient C: 12 weeks = first trimester — "not recommended" (section 4.6), not "contraindicated" (which applies to second and third trimesters per section 4.3). Patient D: diabetes + aliskiren — contraindicated per section 4.3. Patient E: asthma is not an ACE inhibitor contraindication (though ACE inhibitor cough may mimic asthma symptoms).
Two patients have true contraindications (B and D). The question might ask for the "most clearly contraindicated" or present only one of these as an option.
Exam tip: Examiners deliberately include patients who require caution (section 4.4) alongside patients with true contraindications (section 4.3). The distinction between "must not be used" and "use with caution" is exactly what the question tests. Read the extract precisely — do not import assumptions from clinical experience.
Section 4.4 (Special Warnings): Monitoring Requirements
Questions test whether you know what monitoring is needed when a drug is initiated or continued. The SmPC extract might state that a drug requires baseline renal function and electrolytes before starting, repeat testing at 1-2 weeks, and periodic monitoring thereafter. The question asks what should be arranged.
Worked example 4. SmPC extract: "Renal function and serum potassium should be monitored before initiation, after 1-2 weeks, and then periodically during treatment. More frequent monitoring is recommended in patients with renal impairment." A patient with CKD stage 3 is starting the drug. What monitoring should be arranged? The answer: baseline renal function and potassium before starting, repeat at 1-2 weeks, and ongoing periodic monitoring — with the additional note that CKD warrants more frequent monitoring than the standard schedule.
Section 4.5 (Interactions): The Most Frequently Tested SmPC Section
Interaction questions account for a disproportionate share of SmPC-based GPhC questions. The extract provides an interaction list. The question presents a patient on multiple medications and asks you to identify the significant interaction and its clinical consequence.
Worked example 5. SmPC extract states: "Concomitant use with potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene) or potassium supplements may lead to a significant increase in serum potassium. If concomitant use is indicated, monitor serum potassium closely and frequently." Patient takes ramipril 5mg, spironolactone 25mg, atorvastatin 20mg, and metformin 1g twice daily. What is the most important monitoring requirement related to the drug interactions identified in the SmPC extract?
The answer: serum potassium — the ramipril + spironolactone combination creates hyperkalaemia risk as explicitly described in the extract. The atorvastatin and metformin are distractors — they do not appear in the ACE inhibitor interaction extract provided.
Exam tip: Interaction questions often have multiple correct-sounding answers. The SmPC extract on screen narrows the field — if the interaction is listed in the provided extract, that is the one being tested. Do not answer based on your general pharmacology knowledge; answer based on what the extract says.
Section 4.6 (Pregnancy and Lactation): Consistently Tested
At least one question per sitting involves prescribing in pregnancy or breastfeeding. The extract provides the manufacturer's pregnancy data. The question asks whether the drug is appropriate.
Exam tip: Know the common pregnancy patterns (ACE inhibitors contraindicated in T2/T3, metformin can be used, valproate contraindicated in women of childbearing potential without Pregnancy Prevention Programme). But always read the specific SmPC extract provided — different formulations or brands of the same active substance sometimes have subtly different pregnancy wording.
Section 6 (Pharmaceutical Particulars): Excipient Questions
Section 6.1 lists excipients. Questions test whether you can identify a problematic excipient for a specific patient — a patient with lactose intolerance and a formulation containing lactose monohydrate, a patient with aspirin allergy and a capsule containing azo dyes (E124, E110), a patient with peanut allergy and a formulation containing arachis oil.
Worked example 6. The PJ's GPhC preparation series highlights the naproxen OTC example: the SmPC specifies an age range of 15 to 50 years for the OTC product. A 52-year-old patient requests OTC naproxen. Based on the SmPC, the sale cannot be made — the patient falls outside the licensed OTC age range. This tests SmPC-specific information that many candidates would not know from clinical practice alone, where naproxen is prescribed across all adult age groups.
Exam tip: Always check section 6.1 if the question mentions an allergy or intolerance. Excipient questions reward candidates who read the entire extract carefully, not just the sections they consider "clinical."
Building the Skill: A Daily Practice Protocol
SmPC interpretation is a skill — and like all skills, it improves with deliberate practice.
Daily practice (10 minutes). Pick one drug per day on the emc (medicines.org.uk). Navigate to sections 4.1-4.6 and 6.1. Time yourself answering: What is the dose for a patient with eGFR 25ml/min? (section 4.2). What is the key contraindication? (section 4.3). What is the most clinically significant interaction? (section 4.5). Is this drug safe in pregnancy? (section 4.6). Does this formulation contain lactose? (section 6.1). Target: locate and answer each question within 90 seconds. Build speed through repetition — by exam day, SmPC navigation should feel automatic.
Weekly timed exercise (20 minutes). Simulate the exam experience. Pick an unfamiliar drug. Open its SmPC on the emc. Set a 12-minute timer. Answer 6 clinical questions requiring SmPC section navigation. If you can locate the relevant information and answer correctly within the time limit, your SmPC speed is exam-ready.
Q-bank practice. iatroX's GPhC Q-bank includes questions that mirror the SmPC-extract format — clinical scenarios with SmPC-derived information requiring rapid interpretation and application. The adaptive engine ensures SmPC interpretation skills are tested alongside clinical therapeutics, pharmaceutical calculations, and law — building the full range of CRA competencies in each study session.
The resource pack is not something to fear. It is a clinical tool you will use every day as a registered pharmacist. The exam tests whether you can use it safely and efficiently. Practise now; perform on exam day.